Skip to content
Disclosery

Broadfin Capital, LLC

Follow

13F filer, CIK 1511901, New York, NY

Broadfin Capital, LLC reported $679,523,000 across 50 holdings for the quarter ended 2018-09-30, in a 13F-HR filed 2018-11-14. Its ten largest share positions make up 53.94% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001511901-18-000006

Period
2018-09-30
Reported value
$680M
Holdings
50
Top 10 weight
53.94%
New
16
Sold out
11

Largest buys vs the previous quarter

SecurityShares changeApprox. value
NANOSTRING TECHNOLOGIES INCnew+850,000$15.2M
XENEnew+895,553$11.8M
LA JOLLA PHARMACEUTICAL COadded+559,471$11.3M
IOVAadded+747,756$8.41M
PACBadded+1,438,930$7.78M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
MIRATI THERAPEUTICS INCreduced-662,506-$31.2M
ENDO INTL PLCexited-2,591,573-$24.4M
HORIZON PHARMA PLCreduced-929,043-$18.2M
EXASexited-261,400-$15.6M
CORIUM INTL INCreduced-1,228,500-$11.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2018

Share positions as resolved from 13F-HR 0001511901-18-000006, largest first. % of portfolio is the value over $557,337,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 912,987 shares; 2018Q2: 4,146,605 shares; 2018Q3: 4,894,361 shares 4,894,361$55.1M9.88%+747,756Timeline
LA JOLLA PHARMACEUTICAL COLA JOLLA PHARMACEUTICAL COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,656,720 shares; 2018Q2: 1,494,520 shares; 2018Q3: 2,053,991 shares 2,053,991$41.3M7.42%+559,471
ZOGENIX INC.ZOGENIX INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 537,380 shares; 2018Q2: 622,380 shares; 2018Q3: 657,898 shares 657,898$32.6M5.85%+35,518
ADMAADMA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 720,529 shares; 2018Q2: 3,249,829 shares; 2018Q3: 4,463,829 shares 4,463,829$27.7M4.97%+1,214,000Timeline
RETROPHIN INCRETROPHIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,178,226 shares; 2018Q2: 1,048,693 shares; 2018Q3: 938,214 shares 938,214$27M4.84%-110,479
ADAMAS PHARMACEUTICALS INCADAMAS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,135,203 shares; 2018Q2: 1,417,121 shares; 2018Q3: 1,328,424 shares 1,328,424$26.6M4.77%-88,697
TNDMTANDEM DIABETES CARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 570,598 shares; 2018Q3: 573,079 shares 573,079$24.6M4.41%+2,481Timeline
ARATANA THERAPEUTICS INCARATANA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 4,294,426 shares; 2018Q2: 4,294,426 shares; 2018Q3: 4,083,135 shares 4,083,135$23.8M4.28%-211,291
CORIUM INTL INCCORIUM INTL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 3,119,645 shares; 2018Q2: 3,597,057 shares; 2018Q3: 2,368,557 shares 2,368,557$22.5M4.04%-1,228,500
CPRXCATALYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 6,812,764 shares; 2018Q2: 6,772,764 shares; 2018Q3: 5,136,264 shares 5,136,264$19.4M3.48%-1,636,500Timeline
MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,443,948 shares; 2018Q2: 1,020,178 shares; 2018Q3: 357,672 shares 357,672$16.8M3.02%-662,506
ANTARES PHARMA INCANTARES PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 4,673,247 shares; 2018Q2: 4,623,247 shares; 2018Q3: 4,623,247 shares 4,623,247$15.5M2.79%0
NANOSTRING TECHNOLOGIES INCNANOSTRING TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 850,000 shares 850,000$15.2M2.72%new
SOCIETAL CDMO INCSOCIETAL CDMO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 2,236,025 shares; 2018Q2: 2,048,025 shares; 2018Q3: 2,048,025 shares 2,048,025$14.6M2.61%0
PACBPACIFIC BIOSCIENCES CALIF INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 1,054,091 shares; 2018Q3: 2,493,021 shares 2,493,021$13.5M2.42%+1,438,930Timeline
IARTINTEGRA LIFESCIENCES HLDGS CQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 298,424 shares; 2018Q2: 163,424 shares; 2018Q3: 196,572 shares 196,572$12.9M2.32%+33,148Timeline
STRONGBRIDGE BIOPHARMA PLCSTRONGBRIDGE BIOPHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 2,793,752 shares; 2018Q2: 2,340,649 shares; 2018Q3: 2,563,096 shares 2,563,096$12.4M2.23%+222,447
AVADEL PHARMACEUTICALS, PLCAVADEL PHARMACEUTICALS, PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 2,624,663 shares; 2018Q2: 2,724,663 shares; 2018Q3: 2,792,773 shares 2,792,773$12.3M2.2%+68,110
BIODELIVERY SCIENCES INTL INBIODELIVERY SCIENCES INTL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 4,278,819 shares; 2018Q2: 4,278,819 shares; 2018Q3: 4,375,066 shares 4,375,066$12.2M2.2%+96,247
TELIGENT INC NEWTELIGENT INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,690,794 shares; 2018Q2: 2,999,817 shares; 2018Q3: 3,052,852 shares 3,052,852$12.1M2.16%+53,035
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 895,553 shares 895,553$11.8M2.12%newTimeline
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,581,416 shares; 2018Q2: 519,787 shares; 2018Q3: 291,213 shares 291,213$9.22M1.65%-228,574Timeline
HORIZON PHARMA PLCHORIZON PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 2,564,175 shares; 2018Q2: 1,339,575 shares; 2018Q3: 410,532 shares 410,532$8.04M1.44%-929,043
STRATA SKIN SCIENCES INCSTRATA SKIN SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 203,346 shares; 2018Q2: 2,943,819 shares; 2018Q3: 2,181,363 shares 2,181,363$7.72M1.39%-762,456
SIERRA ONCOLOGY INCSIERRA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 2,106,589 shares; 2018Q3: 4,090,344 shares 4,090,344$6.95M1.25%+1,983,755
INTERSECT ENT INCINTERSECT ENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 234,200 shares 234,200$6.73M1.21%new
SOL GEL TECHNOLOGIESSOL GEL TECHNOLOGIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 647,700 shares; 2018Q2: 647,700 shares; 2018Q3: 847,700 shares 847,700$6.36M1.14%+200,000
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 72,100 shares; 2018Q3: 51,000 shares 51,000$6.32M1.13%-21,100Timeline
ANGOANGIODYNAMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 911,707 shares; 2018Q2: not reported; 2018Q3: 289,035 shares 289,035$6.28M1.13%newTimeline
QUOTIENT LTDQUOTIENT LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 439,700 shares; 2018Q3: 804,700 shares 804,700$6.08M1.09%+365,000
NOVELION THERAPEUTICS INCNOVELION THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,948,554 shares; 2018Q2: 1,948,554 shares; 2018Q3: 1,948,554 shares 1,948,554$5.77M1.03%0
IDERA PHARMACEUTICALS INCIDERA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 629,340 shares 629,340$5.61M1.01%new
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 62,200 shares 62,200$5.44M0.98%newTimeline
TESARO INCTESARO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 104,700 shares 104,700$4.08M0.73%new
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 24,200 shares 24,200$3.46M0.62%newTimeline
KALA BIO INC COMKALA BIO INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 681,239 shares; 2018Q2: 598,586 shares; 2018Q3: 346,083 shares 346,083$3.42M0.61%-252,503
PERNIX THERAPEUTICS HLDGS INPERNIX THERAPEUTICS HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 15,000,000 shares; 2018Q2: 15,000,000 shares; 2018Q3: 15,000,000 shares 15,000,000$3.38M0.61%0
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 150,000 shares 150,000$3.32M0.6%newTimeline
VRAYQVIEWRAY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 250,000 shares 250,000$2.34M0.42%newTimeline
SCYNEXIS INC COM NEWSCYNEXIS INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,885,904 shares; 2018Q2: 1,885,904 shares; 2018Q3: 1,885,904 shares 1,885,904$2.26M0.41%0
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 1,111,112 shares; 2018Q3: 669,812 shares 669,812$2.26M0.4%-441,300Timeline
VCELVERICEL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 658,900 shares; 2018Q2: not reported; 2018Q3: 132,600 shares 132,600$1.88M0.34%newTimeline
ONCOMED PHARMACEUTICALS INC…ONCOMED PHARMACEUTICALS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 200,000 shares 200,000$424K0.08%new

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
IWMISHARES TR SHSput400,000$67.4Mnew
AMARIN CORP PLCAMARIN CORP PLC SPONS ADR NEWcall1,455,000$23.7M0
XBISPDR SERIES TRUST S&P BIOTECHput160,000$15.3Mnew
GLOBAL BLOOD THERAPEUTICS U…GLOBAL BLOOD THERAPEUTICS USD COMcall150,000$5.7Mnew
TESARO INCTESARO INC COMcall125,000$4.88M0
HRTXHERON THERAPEUTICS INC COMcall100,000$3.17M0
LA JOLLA PHARMACEUTICAL COLA JOLLA PHARMACEUTICAL CO COM PAR $.0001 2call100,000$2.01Mnew

Sold out in Q3 2018

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ENDO INTL PLCENDO INTL PLC2,591,573$24.4Mshares
EXASEXACT SCIENCES CORP261,400$15.6Mshares
ZOGENIX INC.ZOGENIX INC.335,000$14.8Mput
XRAYDENTSPLY SIRONA INC262,900$11.5Mshares
ENDO INTL PLCENDO INTL PLC1,200,000$11.3Mcall
MTDMETTLER TOLEDO INTERNATIONAL11,900$6.89Mshares
XERIS PHARMACEUTICALS INCXERIS PHARMACEUTICALS INC250,000$4.75Mshares
GLOBAL BLOOD THERAPEUTICS U…GLOBAL BLOOD THERAPEUTICS USD80,100$3.62Mshares
MEDIWOUND LTDMEDIWOUND LTD477,100$3.29Mshares
ODONATE THERAPEUTICS INCODONATE THERAPEUTICS INC93,081$2.06Mshares
IOVAIOVANCE BIOTHERAPEUTICS INC27,500$352Kcall

How Q3 2018 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001511901-18-000006 base2018-11-14acceptance time not in the bulk data set